Evaluation of the Safety of Primaquine in Combination With Artemether-lumefantrine in Glucose-6-phosphate Dehydrogynase Deficient Males With an Asymptomatic Malaria Infection in Burkina Faso (SAFEPRIM)

Trial Profile

Evaluation of the Safety of Primaquine in Combination With Artemether-lumefantrine in Glucose-6-phosphate Dehydrogynase Deficient Males With an Asymptomatic Malaria Infection in Burkina Faso (SAFEPRIM)

Completed
Phase of Trial: Phase II/III

Latest Information Update: 12 Feb 2016

At a glance

  • Drugs Artemether/lumefantrine (Primary) ; Primaquine
  • Indications Malaria
  • Focus Therapeutic Use
  • Acronyms SAFEPRIM
  • Most Recent Events

    • 29 Jan 2016 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 31 Mar 2015 Planned End Date changed from 1 Jan 2015 to 1 Sep 2015, according to to ClinicalTrials.gov record.
    • 31 Mar 2015 Planned primary completion date changed from 1 Dec 2014 to 1 Jul 2015, according to to ClinicalTrials.gov record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top